Melatonin restores the cytochrome oxidase reactivity in the nodose ganglia of acute hypoxic rats

Journal of Pineal Research

Volumn 39, Issue 2, 2005, Pages 206-214

  Chang, Hung Ming ^a   Tseng, Chi Yu ^b   Wei, I Hua ^c   Lue, June Horng ^c   Wen, Chen Yuan ^c   Shieh, Jeng Yung ^c  

^a CHUNG SHAN MEDICAL UNIVERSITY   (Taiwan)

^b NATIONAL CHENG KUNG UNIVERSITY HOSPITAL   (Taiwan)

^c NATIONAL TAIWAN UNIVERSITY   (Taiwan)

Author keywords

Cytochrome oxidase; Hypoxia; Image analysis; Melatonin; Nitric oxide; Nodose ganglion; Quantitative histochemistry

Indexed keywords

CYTOCHROME C OXIDASE; MELATONIN; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE DEHYDROGENASE;

ACUTE DISEASE; ALTITUDE; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENZYME REACTIVATION; HISTOCHEMISTRY; HYPOXIA; IMMUNOFLUORESCENCE; MALE; NODOSE GANGLION; NONHUMAN; OXIDATIVE STRESS; RAT; UPREGULATION;

ACUTE DISEASE; ANIMALS; ANOXIA; ANTIOXIDANTS; DOSE-RESPONSE RELATIONSHIP, DRUG; ELECTRON TRANSPORT COMPLEX IV; FLUORESCENT ANTIBODY TECHNIQUE; MALE; MELATONIN; NADP; NODOSE GANGLION; RATS; RATS, WISTAR;

EID: 23744456452     PISSN: 07423098     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-079X.2005.00238.x     Document Type: Article

References (56)

1. HADDAD GG, JIANG C. O2 deprivation in the central nervous system: on mechanisms of neuronal response, differential sensitivity and injury. Prog Neurobiol 1993; 40:277-318.
2. ZHUO H, ICHIKAWA H, HELKE CJ. Neurochemistry of the nodose ganglion. Prog Neurobiol 1997; 52:79-107.
3. CHANG HM, LIAO WC, LUE JH et al. Upregulation of NMDA receptor and neuronal NADPH-d/NOS expression in the no-dose ganglion of acute hypoxic rats. J Chem Neuroanat 2003; 25:137-147.
4. FARBER JL, CHIEN KR, MITTNACHT S Jr. The pathogenesis of irreversible cell injury in ischemia. Am J Pathol 1981; 102:271-281.
5. IKONOMIDOU C, PRICE MT, MOSINGER JL et al. Hypobaric-ischemic conditions produce glutamate-like cytopathology in infant rat brain. J Neurosci 1989; 9:1693-1700.
6. VANNUCCI RC. Experimental biology of cerebral hypoxia-ischemia: relation to perinatal brain damage. Pediatr Res 1990; 27:317-326.
7. PEARIGEN P, GWINN R, SIMON RP. The effects of in vivo hypoxia on brain injury. Brain Res 1996; 725:184-191.
8. CÁCEDA R, GAMBOA JL, BOERO JA et al. Energetic metabolism in mouse cerebral cortex during chronic hypoxia. Neurosci Lett 2001; 301:171-174.
9. ANG RC, HOOP B, KAZEMI H. Role of glutamate as the central neurotransmitter in the hypoxic ventilatory response. J Appl Physiol 1992; 72:1480-1487.
10. MIZUSAWA A, OGAWA H, KIKUCHI Y et al. In vivo release of glutamate in nucleus tractus solitarii of the rat during hypoxia. J Physiol 1994; 478:55-66.
11. OHTAKE PJ, TORRES JE, GOZAL YM et al. NMDA receptors mediate peripheral chemoreceptor afferent input in the conscious rat. J Appl Physiol 1998; 84:853-861.
12. GUNASEKAR PG, KANTHASAMY AG, BOROWITZ JL et al. NMDA receptor activation produces concurrent generation of nitric oxide and reactive oxygen species: implication for cell death. J Neurochem 1995; 65:2016-2021.
13. ZANELLI SA, NUMAGAMI Y, MCGOWAN JE et al. NMDA receptor-mediated calcium influx in cerebral cortical synaptosomes of the hypoxic guinea pig fetus. Neurochem Res 1995; 24:437-446.
14. MANDER P, BROWN GC. Nitric oxide, hypoxia and brain inflammation. Biochem Soc Trans 2004; 32:1068-1069.
15. BEAL MF. Mitochondrial dysfunction in neurodegenerative diseases. Biochem Biophys Acta 1998; 1366:211-223.
16. SKULACHEV VP. Mitochondrial physiology and pathology: concepts or programmed death of organelles, cells and organisms. Mol Aspects Med 1999; 20:139-184.
17. SASTRE J, PALLARDO FV, GARCÍA DE LA et al. Mitochondria, oxidative stress and aging. Free Rad Res 2000; 32:189-198.
18. CAPALDI RA. Structure and function of cytochrome c oxidase. Annu Rev Biochem 1990; 59:569-596.
19. REGAN JJ, RAMIREZ BE, WINKLER JR et al. Pathways for electron tunneling in cytochrome c oxidase. J Bioenerg Biomembr 1998; 30:35-39.
20. WONG-RILEY MTT. Cytochrome oxidase: an endogenous metabolic marker for neuronal activity. Trends Neurosci 1989; 12:94-101.
21. WONG-RILEY MTT, MERZENICH MM, LEAKE PA. Changes in endogenous enzymatic reactivity to DAB induced by neuronal inactivity. Brain Res 1978; 141:185-192.
22. WONG-RILEY MTT. Changes in the visual system of monocularly sutured or enucleated cats demonstrable with cytochrome oxidase histochemistry. Brain Res 1979; 171:11-28.
23. WONG-RILEY MTT, WELT C. Histochemical changes in cytochrome oxidase of cortical barrels after vibrissal removal in neonatal and adult mice. Proc Natl Acad Sci U S A 1980; 77:2333-2337.
24. KAGEYAMA GH, WONG-RILEY MTT. Histochemical localization of cytochrome oxidase in the hippocampus: correlation with specific neuronal types and afferent pathways. Neuroscience 1982; 10:2337-2361.
25. ICHIKAWA H, HELKE CJ. Cytochrome oxidase activity in vagal and glossopharyngeal visceral sensory neurons of the rat: effect of peripheral axotomy. Brain Res 1992; 578:311-316.
26. IANNUZZELLI PG, WANG XH, WANG Y et al. Axotomy-induced changes in cytochrome oxidase activity in the cat trochlear nucleus. Brain Res 1994; 637:267-272.
27. LAMANNA JC, KUTINA-NELSON KL, HRITZ MA et al. Decreased rat brain cytochrome oxidase activity after prolonged hypoxia. Brain Res 1996; 720:1-6.
28. TAN DX, CHEN LD, POEGGELER B et al. Melatonin: a potent, endogenous hydroxyl radical scavenger. Endocr J 1993; 1:57-60.
29. REITER RJ, TANG L, GARCIA JJ et al. Pharmacological actions of melatonin in oxygen radical pathophysiology. Life Sci 1997; 60:2255-2271.
30. REITER RJ. Oxidative damage in the central nervous system: protection by melatonin. Prog Neurobiol 1998; 56:359-384.
31. ALLEGRA M, REITER RJ, TAN DX et al. The chemistry of melatonin's interaction with reactive species. J Pineal Res 2003; 34:1-10.
32. MONTILLA P, VARGAS J, TÚNEZ I et al. Oxidative stress in diabetic rats induced by streptozotocin: protective effects of melatonin. J Pineal Res 1998; 25:94-100.
33. REITER RJ, CABRERA J, SAINZ RM et al. Melatonin as a pharmacological agent against neuronal loss in experimental models of Huntington's disease, Alzheimer's disease and Parkinsonism. Ann N Y Acad Sci 1999; 890:471-485.
34. CHEUNG RTF. The utility of melatonin in reducing cerebral damage resulting from ischemia and reperfusion. J Pineal Res 2003; 34:153-160.
35. CHANG HM, LING EA, LUE JH et al. Melatonin attenuates neuronal NADPH-d/NOS expression in the hypoglossal nucleus of adult rats following peripheral nerve injury. Brain Res 2000; 873:243-251.
36. MARTIN M, MACÍS M, ESCAMES G et al. Melatonin-induced increased activity of the respiratory chain complexes I and IV can prevent mitochondrial damage induced by ruthenium red in vivo. J Pineal Res 2000; 28:242-248.
37. LEON J, ACUNA-CASTROVIEJO D, ESCAMES G et al. Melatonin mitigates mitochondrial malfunction. J Pineal Res 2005; 38: 1-7.
38. SMOLEN AJ. Image analysis techniques for quantification of immunohistochemical staining in the nervous system. In: Methods in Neuroscience: Quantitative and Qualitative Microscopy. Conn PM, ed. Academic Press, San Diego, CA, 1990; pp. 208-229.
39. JONES EG, HENDRY SHC, BRANDON C. Cytochrome oxidase staining reveals functional organization of monkey somatosensory thalamus. Exp Brain Res 1986; 62:438-442.
40. SARAIVA AA, BORGES MM, MADEIRA MD et al. Mitochondrial abnormalities in cortical dendrites from patients with Alzheimer's disease. J Submicrosc Cytol 1985; 17:459-464.
41. SNYDER SH, BREDT DS. Biological roles of nitric oxide. Sci Am 1992; 226:68-77.
42. MURPHY MP. Nitric oxide and cell death. Biochim Biophys Acta 1999; 1411:401-414.
43. BROWN GC. Nitric oxide and mitochondrial respiration. Biochim Biophys Acta 1999; 1411:351-369.
44. COOPER CE. Nitric oxide and cytochrome oxidase: substrate, inhibitor or effector? Trends Biochem Sci 2002; 27:33-39.
45. SARTI P, GIUFFRE A, BARONE MC et al. Nitric oxide and cytochrome oxidase: reaction mechanisms from the enzyme to the cell. Free Rad Biol Med 2003; 34:509-520.
46. WEI IH, Wu YC, WEN CY et al. Green tea polyphenol (-)-epigallocatechin gallate attenuates the neuronal NADPH-d/NOS expression in the nodose ganglion of acute hypoxic rats. Brain Res 2004; 999:73-80.
47. MESENGE C, MARGAILL I, VERRECCHIA C et al. Protective effect of melatonin in a model of traumatic brain injury in mice. J Pineal Res 1998; 25:41-46.
48. THOMAS B, MOHANAKUMAR KP. Melatonin protects against oxidative stress caused by 1-methyl-4-phenyl-1,2,3,6-tetra-hydropyridine in the mouse nigrostriatum. J Pineal Res 2004; 36:25-32.
49. MENÉNDEZ-PELÁEZ A, POEGGELER B, REITER RJ et al. Nuclear localization of melatonin in different mammalian tissues. Immunocytochemical and radioimmunoassay evidence. J Cell Biochem 1993; 53:373-382.
50. GARCIA JJ, REITER RJ, PIE J et al. Role of pinoline and melatonin in stabilizing hepatic microsomal membranes against oxidative damage. J Bioenerg Biomem 1999; 31:609-616.
51. GILAD E, CUZZOCREA S, ZINGARELLI B et al. Melatonin is a scavenger of peroxynitrite. Life Sci 1997; 60:169-174.
52. TAN DX, MANCHESTER LC, REITER RJ et al. Melatonin directly scavenges hydrogen peroxide: a potentially new metabolic pathway of melatonin biotransformation. Free Rad Biol Med 2000; 29:1177-1185.
53. POZO D, REITER RJ, CALVO JR et al. Inhibition of cerebellar nitric oxide synthase and cyclic GMP production by melatonin via complex formation with calmodulin. J Cell Biochem 1997; 65:430-442.
54. ANTOLÍN I, RODRIGUEZ C, SAINZ RM et al. Neurohormone melatonin prevents cell damage: effect on gene expression for antioxidant enzymes. FASEB J 1996; 10:882-890.
55. RODRIGUEZ C, MAYO JC, SAINZ RM et al. Regulation of antioxidant enzymes: a significant role for melatonin. J Pineal Res 2004; 36:1-9.
56. CHANG HM, LUE JH, WEN CY et al. Axotomy along with hypoxia enhances the neuronal NADPH-d/NOS expression in lower brain stem motor neurons of adult rats. Exp Neurol 2001; 171:116-126.